openPR Logo
Press release

G-Protein Coupled Receptors (GPCRs) to Surpass $5.42 Billion by 2030 with a 6.7 Percentage CAGR

09-13-2024 09:15 AM CET | Health & Medicine

Press release from: MAXIMIZE MARKET RESEARCH PVT. LTD.

G-Protein Coupled Receptors (GPCRs) Market

G-Protein Coupled Receptors (GPCRs) Market

๐€๐ง๐ญ๐ข๐œ๐ข๐ฉ๐š๐ญ๐ž๐ ๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐ข๐ง ๐ˆ๐ง๐œ๐จ๐ฆ๐ž:

The market for GPCRs (g-protein coupled receptors) is anticipated to grow at a compound annual growth rate of 6.7% to reach US$ 5.42 billion by 2030.

๐Ž๐ฏ๐ž๐ซ๐ฏ๐ข๐ž๐ฐ ๐จ๐Ÿ ๐ญ๐ก๐ž ๐†-๐๐ซ๐จ๐ญ๐ž๐ข๐ง ๐‚๐จ๐ฎ๐ฉ๐ฅ๐ž๐ ๐‘๐ž๐œ๐ž๐ฉ๐ญ๐จ๐ซ๐ฌ (๐†๐๐‚๐‘๐ฌ) ๐Œ๐š๐ซ๐ค๐ž๐ญ:

The G-Protein Coupled Receptors (GPCRs) market is a rapidly growing sector within the pharmaceutical and biotechnology industries, driven by their pivotal role in signal transduction and drug discovery. GPCRs, which are integral membrane proteins, serve as key targets for a wide range of therapeutic applications, including cardiovascular, neurological, and metabolic disorders. The increasing prevalence of these diseases, coupled with advancements in drug development technologies and a deeper understanding of GPCR structures, is fueling market expansion. Major pharmaceutical companies are heavily investing in GPCR-targeted drug research, while collaborations between academic institutions and industry players are accelerating innovation. This dynamic market is expected to witness significant growth, driven by the demand for precision medicine and novel therapeutic interventions.

๐˜๐จ๐ฎ๐ซ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐ˆ๐ฌ ๐‰๐ฎ๐ฌ๐ญ ๐š ๐‚๐ฅ๐ข๐œ๐ค ๐€๐ฐ๐š๐ฒ :https://www.maximizemarketresearch.com/request-sample/104389/

๐ƒ๐ซ๐ข๐ฏ๐ž๐ซ๐ฌ ๐ข๐ง ๐ญ๐ก๐ž ๐†-๐๐ซ๐จ๐ญ๐ž๐ข๐ง ๐‚๐จ๐ฎ๐ฉ๐ฅ๐ž๐ ๐‘๐ž๐œ๐ž๐ฉ๐ญ๐จ๐ซ๐ฌ (๐†๐๐‚๐‘๐ฌ) ๐Œ๐š๐ซ๐ค๐ž๐ญ:

Key drivers in the G-Protein Coupled Receptors (GPCRs) market include the rising prevalence of chronic diseases such as cardiovascular, neurological, and metabolic disorders, which demand novel therapeutic interventions. Advances in drug discovery technologies, including high-throughput screening and structural biology, are facilitating more efficient targeting of GPCRs. The growing focus on precision medicine and personalized therapies is also driving research into GPCR-targeted drugs. Additionally, increasing investments from pharmaceutical companies and partnerships between industry and academic institutions are accelerating innovation. The regulatory approval of new GPCR-based therapies further contributes to the market's growth, providing promising opportunities for future development.

๐†-๐๐ซ๐จ๐ญ๐ž๐ข๐ง ๐‚๐จ๐ฎ๐ฉ๐ฅ๐ž๐ ๐‘๐ž๐œ๐ž๐ฉ๐ญ๐จ๐ซ๐ฌ (๐†๐๐‚๐‘๐ฌ) ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ƒ๐ž๐ฏ๐ž๐ฅ๐จ๐ฉ๐ฆ๐ž๐ง๐ญ๐ฌ:

The G-protein coupled receptors (GPCRs) market is experiencing significant developments, driven by advancements in assay technologies and expanding therapeutic applications. Recent innovations in assay techniques, such as label-free detection and advanced methods like AlphaScreen and Time-resolved fluorescence energy transfer (TR-FRET), have enhanced drug discovery by providing more efficient and sensitive tools for studying GPCR signaling. These advancements have made GPCR research faster and more cost-effective, fueling broader adoption in both academic and pharmaceutical settings.

๐๐ž๐ž๐ ๐Œ๐จ๐ซ๐ž ๐ˆ๐ง๐Ÿ๐จ๐ซ๐ฆ๐š๐ญ๐ข๐จ๐ง? ๐ˆ๐ง๐ช๐ฎ๐ข๐ซ๐ž ๐€๐›๐จ๐ฎ๐ญ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž + ๐†๐ซ๐š๐ฉ๐ก๐ฌ ๐‡๐ž๐ซ๐ž:https://www.maximizemarketresearch.com/request-sample/104389/

๐†-๐๐ซ๐จ๐ญ๐ž๐ข๐ง ๐‚๐จ๐ฎ๐ฉ๐ฅ๐ž๐ ๐‘๐ž๐œ๐ž๐ฉ๐ญ๐จ๐ซ๐ฌ (๐†๐๐‚๐‘๐ฌ) ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐Ž๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐ž๐ฌ:

G-Protein Coupled Receptors (GPCRs) represent one of the most significant families of cell surface receptors, playing a crucial role in various physiological processes by transmitting extracellular signals into the cell. The market for GPCR-based therapeutics and research is robust and expanding, driven by the growing understanding of these receptors' roles in health and disease. Opportunities in this market include the development of new drugs targeting specific GPCR subtypes for conditions such as cancer, cardiovascular diseases, and neurological disorders. Advances in technology, such as high-throughput screening and structural biology, are enhancing the ability to discover and develop novel GPCR-targeted therapies. Additionally, the increasing prevalence of chronic diseases and the demand for personalized medicine are fueling the growth of GPCR research and drug development. Companies and research institutions are exploring innovative approaches, including allosteric modulators and biased agonists, to exploit the therapeutic potential of GPCRs, making this a dynamic and promising field in the pharmaceutical and biotech industries.

๐–๐ก๐š๐ญ ๐ข๐ฌ ๐†-๐๐ซ๐จ๐ญ๐ž๐ข๐ง ๐‚๐จ๐ฎ๐ฉ๐ฅ๐ž๐ ๐‘๐ž๐œ๐ž๐ฉ๐ญ๐จ๐ซ๐ฌ (๐†๐๐‚๐‘๐ฌ) ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ ๐ข๐จ๐ง๐š๐ฅ ๐ˆ๐ง๐ฌ๐ข๐ ๐ก๐ญ?

The G-Protein Coupled Receptors (GPCRs) market exhibits diverse regional dynamics, reflecting varying levels of research activity, healthcare infrastructure, and regulatory environments. In North America, particularly the United States, there is a robust market driven by advanced research facilities, substantial funding, and a strong pharmaceutical industry focused on GPCR-targeted therapies. Europe also holds a significant share, with countries like Germany, the UK, and Switzerland leading in GPCR research and development due to their established biotech sectors and favorable regulatory frameworks. In Asia-Pacific, the market is expanding rapidly, especially in China and Japan, due to increasing investments in biotechnology and growing healthcare needs. Emerging markets in Latin America and the Middle East are beginning to show interest, with improving healthcare systems and rising research initiatives contributing to the overall growth. Each region presents unique opportunities and challenges, influenced by local healthcare demands, regulatory practices, and research capabilities, shaping the global landscape of the GPCR market.

๐‚๐ฎ๐ซ๐ข๐จ๐ฎ๐ฌ ๐ญ๐จ ๐ฉ๐ž๐ž๐ค ๐ข๐ง๐ฌ๐ข๐๐ž? ๐†๐ซ๐š๐› ๐ฒ๐จ๐ฎ๐ซ ๐ฌ๐š๐ฆ๐ฉ๐ฅ๐ž ๐œ๐จ๐ฉ๐ฒ ๐จ๐Ÿ ๐ญ๐ก๐ข๐ฌ ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ ๐ง๐จ๐ฐ:https://www.maximizemarketresearch.com/request-sample/104389/

๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ ๐จ๐Ÿ ๐ญ๐ก๐ž ๐†-๐๐ซ๐จ๐ญ๐ž๐ข๐ง ๐‚๐จ๐ฎ๐ฉ๐ฅ๐ž๐ ๐‘๐ž๐œ๐ž๐ฉ๐ญ๐จ๐ซ๐ฌ (๐†๐๐‚๐‘๐ฌ) ๐Œ๐š๐ซ๐ค๐ž๐ญ:

๐›๐ฒ ๐๐ซ๐จ๐๐ฎ๐œ๐ญ

Cell Lines
Detection Kits
Cell Culture Reagents
Ligands

๐›๐ฒ ๐€๐ฌ๐ฌ๐š๐ฒ ๐“๐ฒ๐ฉ๐ž

cAMP Functional Assays
Calcium Functional Assays
ฮฒ-Arrestin Functional Assays
Radioligand Binding and GTPฮณS Functional Assays
Internalization Assays
Trafficking Assays
Other Assays

๐›๐ฒ ๐€๐ฉ๐ฉ๐ฅ๐ข๐œ๐š๐ญ๐ข๐จ๐ง

Cancer Research
CNS Research
Metabolic Research
Cardiovascular Research
Respiratory Research
Inflammation Research
Other Application

๐–๐ก๐จ ๐ข๐ฌ ๐ญ๐ก๐ž ๐ฅ๐š๐ซ๐ ๐ž๐ฌ๐ญ ๐ฆ๐š๐ง๐ฎ๐Ÿ๐š๐œ๐ญ๐ฎ๐ซ๐ž๐ซ๐ฌ ๐จ๐Ÿ ๐†-๐๐ซ๐จ๐ญ๐ž๐ข๐ง ๐‚๐จ๐ฎ๐ฉ๐ฅ๐ž๐ ๐‘๐ž๐œ๐ž๐ฉ๐ญ๐จ๐ซ๐ฌ (๐†๐๐‚๐‘๐ฌ) ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ฐ๐จ๐ซ๐ฅ๐๐ฐ๐ข๐๐ž?

Thermo Fisher Scientific, Inc.
Becton, and Dickinson and Company
Abcam plc.
Enzo Life Sciences, Inc.
Promega Corporation.
PerkinElmer Inc.
QIAGEN
Merck KGaA
HD Biosciences Co., Ltd
Cisbio Bioassays
Eurofins DiscoverX Products.
Actelion Pharmaceuticals Ltd
Accure Pharma
Anchor Therapeutics.
Arena Pharmaceuticals, Inc.
ADDEX THERAPEUTICS
WuXi AppTec
BioInvenu, Inc.
Molecular Devices, LLC.
Corning Incorporated

๐Š๐ง๐จ๐ฐ ๐Œ๐จ๐ซ๐ž ๐€๐›๐จ๐ฎ๐ญ ๐“๐ก๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ:https://www.maximizemarketresearch.com/market-report/global-g-protein-coupled-receptors-gpcrs-market/104389/ ๏ปฟ๏ปฟ

๐Š๐ž๐ฒ ๐Ž๐Ÿ๐Ÿ๐ž๐ซ๐ข๐ง๐ ๐ฌ:

Past Market Size and Competitive Landscape
G-Protein Coupled Receptors (GPCRs) Market Size, Share, Size & Forecast by different segment
Market Dynamics - Growth Drivers, Restraints, Opportunities, and Key Trends by region
G-Protein Coupled Receptors (GPCRs) Market Segmentation - A detailed analysis by Product
Competitive Landscape - Profiles of selected key players by region from a strategic perspective
Competitive landscape - Market Leaders, Market Followers, Regional player
Competitive benchmarking of key players by region
PESTLE Analysis
PORTER's analysis
Value chain and supply chain analysis
Legal Aspects of business by region
Lucrative business opportunities with SWOT analysis
Recommendations

๐„๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ž ๐จ๐ฎ๐ซ ๐ญ๐จ๐ฉ-๐ฉ๐ž๐ซ๐Ÿ๐จ๐ซ๐ฆ๐ข๐ง๐  ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ ๐จ๐ง ๐ญ๐ก๐ž ๐ฅ๐š๐ญ๐ž๐ฌ๐ญ ๐ญ๐ซ๐ž๐ง๐๐ฌ:

โ™ฆ Global Aluminum Foams Market https://www.maximizemarketresearch.com/market-report/global-aluminum-foams-market/102066/

โ™ฆ Global Zinc Citrate Market https://www.maximizemarketresearch.com/market-report/global-zinc-citrate-market/116217/

โ™ฆ Global Plastic Ampoules Market https://www.maximizemarketresearch.com/market-report/global-plastic-ampoules-market/42347/

โ™ฆ Aircraft Lavatory System Market https://www.maximizemarketresearch.com/market-report/aircraft-lavatory-system-market/148067/

โ™ฆ Global Smart Condition Monitoring Market https://www.maximizemarketresearch.com/market-report/global-smart-condition-monitoring-market/80192/

โ™ฆ North America OTA Testing Market https://www.maximizemarketresearch.com/market-report/north-america-ota-testing-market/8050/

โ™ฆ IBM Bluemix Services Market https://www.maximizemarketresearch.com/market-report/global-ibm-bluemix-services-market/43240/

โ™ฆ Global Counterfeit Money Detectors Market https://www.maximizemarketresearch.com/market-report/global-counterfeit-money-detectors-market/97456/

โ™ฆ Global IoT in Utilities Market https://www.maximizemarketresearch.com/market-report/global-iot-in-utilities-market/97603/

โ™ฆ Global Center Stack Display Market https://www.maximizemarketresearch.com/market-report/global-center-stack-display-market/116305/

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ ๐Œ๐š๐ฑ๐ข๐ฆ๐ข๐ณ๐ž ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก:

MAXIMIZE MARKET RESEARCH PVT. LTD.
โฎ 3rd Floor, Navale IT park Phase 2,
Pune Banglore Highway, Narhe
Pune, Maharashtra 411041, India.
โœ† +91 9607365656
๐Ÿ–‚ sales@maximizemarketresearch.com
๐ŸŒ www.maximizemarketresearch.com

๐€๐›๐จ๐ฎ๐ญ ๐Œ๐š๐ฑ๐ข๐ฆ๐ข๐ณ๐ž ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก:

Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare and others.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release G-Protein Coupled Receptors (GPCRs) to Surpass $5.42 Billion by 2030 with a 6.7 Percentage CAGR here

News-ID: 3654580 • Views: โ€ฆ

More Releases from MAXIMIZE MARKET RESEARCH PVT. LTD.

Ready-to-Drink Beverages Market Size to Reach USD 1,227.81 Billion by 2032
Ready-to-Drink Beverages Market Size to Reach USD 1,227.81 Billion by 2032
Ready-to-Drink Beverages Market is poised for substantial growth over the forecast period, driven by changing consumer lifestyles, rising disposable income, expanding urbanization, and increasing demand for convenient beverage solutions. According to recent industry analysis, the global Ready-to-Drink Beverages Market was valued at USD 766.69 Billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 6.22% from 2025 to 2032, reaching nearly USD 1,227.81 Billionโ€ฆ
Second hand Product Market Set to Surpass USD 1451.34 Billion by 2032, Expanding at a Robust 13.6% CAGR
Second hand Product Market Set to Surpass USD 1451.34 Billion by 2032, Expanding โ€ฆ
Second hand Product Market was valued at USD 594.45 Billion in 2025 and is projected to grow at a robust CAGR of 13.6% from 2025 to 2032, reaching nearly USD 1451.34 Billion by 2032. The rapid expansion of resale ecosystems, increasing consumer preference for cost-effective purchasing, and rising sustainability awareness are significantly driving the growth of the Second hand Product Market globally. Market Overview The Second hand Product Market is undergoing aโ€ฆ
Tungsten Market to Reach USD 10.99 Billion by 2032, Driven by Expanding Aerospace, Automotive, and Industrial Applications
Tungsten Market to Reach USD 10.99 Billion by 2032, Driven by Expanding Aerospac โ€ฆ
The Global Tungsten Market is poised for significant expansion over the coming years, with the market size valued at USD 6.41 Billion in 2025 and projected to grow at a CAGR of 8% from 2025 to 2032, reaching nearly USD 10.99 Billion by 2032. Rising industrial demand, technological advancements in material science, and increasing applications in high-performance sectors are collectively driving this steady growth trajectory. Tungsten, recognized for its exceptional hardness,โ€ฆ
System-on-Chip (SoC) Market to Reach USD 391.61 Billion by 2032, Driven by 5G, AI, and IoT Expansion
System-on-Chip (SoC) Market to Reach USD 391.61 Billion by 2032, Driven by 5G, A โ€ฆ
The global System-on-Chip (SoC) Market is poised for significant growth over the forecast period, reflecting the rapid evolution of semiconductor technologies and increasing demand for high-performance, energy-efficient electronic devices. Valued at USD 228.06 Billion in 2025, the market is projected to grow at a CAGR of 8.03% from 2025 to 2032, reaching nearly USD 391.61 Billion by 2032. โ™ฆ Request a Free Sample Copy or View Report Summary:https://www.maximizemarketresearch.com/request-sample/33954/ System-on-Chip (SoC) Market Overview Aโ€ฆ

All 5 Releases


More Releases for GPCR

United States G-protein Coupled Receptor (GPCR) Targeting Market Insights | Drug โ€ฆ
G-protein Coupled Receptor (GPCR) Targeting Market is Expected to reach at a high CAGR of 6.40% during the forecast period (2024-2031). Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/g-protein-coupled-receptor-targeting-market?kb United States: Recent Industry Developments โœ… December 2025: A major U.S. biopharma advanced a nextโ€generation GPCRโ€targeted small molecule into lateโ€stage clinical trials for metabolic and inflammatory diseases. โœ… November 2025: Research teams reported promising preclinical resultsโ€ฆ
United States G-Protein Coupled Receptor (GPCR) Targeting Market 2025 | Growth D โ€ฆ
Market Size and Growth G-protein Coupled Receptor (GPCR) Targeting Market is Expected to reach at a high CAGR of 6.40% during the forecast period (2024-2031). Key Development: United States: Recent Developments in GPCR Targeting โœ… In August 2025, Nxera Pharma announced the launch of an expanded drug discovery pipeline targeting obesity and related metabolic diseases. The company is focusing on a range of validated GPCR targets, building on existing collaborations with Pfizer andโ€ฆ
Revolutionary Growth in G-Protein Coupled Receptor (GPCR) Targeting Market: A $6 โ€ฆ
Market Overview: Unprecedented Expansion in GPCR Technologies The G-Protein Coupled Receptor (GPCR) targeting market stands as one of the most dynamic and rapidly evolving sectors in biotechnology today. The G-protein coupled receptor (GPCR) targeting market was valued at approximately USD 3.56 billion in 2023 and is anticipated to reach USD 6.88 billion by 2033, growing at a CAGR of 6.4% from 2024 to 2033. This remarkable growth trajectory positions GPCR targetingโ€ฆ
GPCR Assay Market Is Anticipated To Grow In A Promising Manner between 2023-2030 โ€ฆ
The report discusses everything a marketer requires before investing in the global GPCR Assay Market during the forecast period 2023-2030. It provides detailed insight into current trends, market shares, market size, and sales value and volume. The data used for this report is obtained from reliable industry sources, paid resources, and validated sources. This research works as a systematic guideline for marketers to make well-informed decisions. ๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐š ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‚๐จ๐ฉ๐ฒ ๐จ๐Ÿโ€ฆ
G-Protein Coupled Receptor (GPCR) Targeting Market Analysis, Size, Share, Curren โ€ฆ
The G-Protein Coupled Receptor (GPCR) Targeting Market report discusses in-depth the growth opportunities, challenges, growth drivers, restraints, threats, and demands of the market. Further, the research assesses the regional market as well as the global market to gather the data into the scope of the G-Protein Coupled Receptor (GPCR) Targeting market. The report also provides estimations and forecasts about the market segment and sub-segments exhibiting favorable growth in the upcomingโ€ฆ
G-Protein Coupled Receptor (GPCR) Targeting Market 2022 | Detailed Report
ReportsnReports publishes the report titled G-Protein Coupled Receptor (GPCR) Targeting that presents a 360-degree overview of the market under one roof. The report is developed with the meticulous efforts of an enthusiastic and experienced team of experts, analyts, and researchers that makes the report a valuable asset for stakeholders to make robust decisions. This report also provides an in-depth overview of product type, specification, technology, and production analysis considering vitalโ€ฆ